Sign up to receive both private and institutional investors access to the latest equity research from around the globe. Don't Miss Out.
The word vaccine seems to be the driver of markets, if only sentiment, with Moderna the latest drug company to throw its hat in the COVID-19 ring.
A tumultuous week in the markets. Initial exuberance over a COVID-19 vaccine was then stunted as realisation dawns this is no instant panacea.
The US presidential elections have provided some humour, and despair - this is as good as it gets in the land of the free and the home of the brave.
MultiChoice has been attracting the attention of Canal+ SA which we learned this week has so far acquired 12% of the company.
First off, three cheers to Brian Joffe and his team at Long4Life for ploughing through an unenviable six months bearing the brunt of various levels of lockdown.
In "Gold a must?" this week we point out that whilst oil may not seem related to gold in fact the COVID-19 induced turmoil in the oil market back in April was a precursor of...